GILEAD SCIENCES NORWAY AS
Developing transformative medicines for life-threatening diseases globally.
Oversigt
- 5
- Medarbejdere
- 186.2mio NOK
- Omsætning
- 2007
- Grundlagt
Nøglebeslutningstagere
Stacey Ma
Executive Vice President, Pharmaceutical Development and Manufacturing
Daniel O’Day
Chairman and Chief Executive Officer
Andrew Dickinson
Chief Financial Officer
Jyoti Mehra
Executive Vice President, Human Resources
+6 flere kontakter i Funnelfeedr
Beskrivelse
Gilead Sciences is a research-based biopharmaceutical company dedicated to discovering, developing, and delivering innovative therapeutics for people with life-threatening diseases. The organization focuses its scientific rigor on three primary therapeutic areas: virology, oncology, and inflammation...